← SynDRA
MEFENAMIC ACID
SynDRA canonical compound SYN0001399 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | primary dysmenorrhea (PD) |
|---|
| Disease area | endocrinology |
|---|
All known targets
- PTGS2
- PTGS1
- KCNQ1
- TRPM3
- MPO
- TRPA1
- Nlrp3
- NAPRT
- AKR1B1
- AKR1B10
- KCNMA1
- DHFR
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
- KCNMA1 MODULATOR
- KCNQ1 MODULATOR
- TRPM3 MODULATOR
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- mefenacid
- mephenamic acid
- mefenamate
- Acide mefenamique
- Acido mefenamico
- Gardan
- Mefenamate
- Mefenaminic acid
- Mephenamic acid
- Mephenaminic acid
- CI-473
- CN-35355
- INF-3355
- J2.344B
- M01AG01
- NSC-94437
- Contraflam
- Dysman-250
- Dysman-500
- Meflam 250
- Meflam 500
- Mendys
- Opustan 250
- Opustan 500
- Ponstan
- Ponstan fte
- Ponstel
- ApoMefenamic
- Bonabol
- Coslan
- Dysman
- Lysalgo
- Mefac
- Mefacit
- Mefedolo
- Mefenacid;Mefenamate
- Mefenaminsaeure
- Mefic
Reported adverse events
- Bleeding
- GI bleed
- Ulceration
- Agranulocytosis
- Stevens-Johnson syndrome
- Angioedema
- Asthma
- Hepatotoxicity
- Hypertension
- Alopecia
- Anaphylactoid reaction
- Anxiety
Look up MEFENAMIC ACID in the interactive SynDRA portal →